Loading...
Market
Will Bharat Serums launch a new vaccine product by June 30, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Bharat Serums, press releases, or product launch events
Story
Mankind Pharma Secures CCI Approval for ₹13,360 Crore Bharat Serums Acquisition
Oct 2, 2024, 02:01 AM
Mankind Pharma has received approval from the Competition Commission of India (CCI) for its acquisition of Bharat Serums and Vaccines Limited. The acquisition deal is valued at ₹13,360 crore (approximately $1.6 billion), though some reports indicate a value of Rs 13,630 crore. This transaction involves Mankind Pharma acquiring 100% shareholding of Bharat Serums and Vaccines Limited. Mankind Pharma is India's fourth-largest drug maker.
View original story
Similar markets
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Yes • 50%
No • 50%
GSK • 33%
Sanofi • 33%
Seqirus • 33%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Yes • 50%
No • 50%
GSK • 25%
Sanofi • 25%
CSL • 25%
None by deadline • 25%
Less than 10 million doses • 25%
10-20 million doses • 25%
20-30 million doses • 25%
More than 30 million doses • 25%
Less than 10% • 25%
10-20% • 25%
20-30% • 25%
More than 30% • 25%
